<SEC-DOCUMENT>0000921895-25-000095-index.html : 20250108
<SEC-HEADER>0000921895-25-000095.hdr.sgml : 20250108
<ACCEPTANCE-DATETIME>20250108172515
ACCESSION NUMBER:		0000921895-25-000095
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250105
FILED AS OF DATE:		20250108
DATE AS OF CHANGE:		20250108

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Ben-Tzvi Avraham
		CENTRAL INDEX KEY:			0001944721
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-50626
		FILM NUMBER:		25519382

	MAIL ADDRESS:	
		STREET 1:		44 ZAYT SHEMEN ST.
		STREET 2:		FLAT 4
		CITY:			EFRAT
		STATE:			L3
		ZIP:			9045544

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Cyclacel Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001130166
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				911766850
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922
		BUSINESS PHONE:		908-517-7330

	MAIL ADDRESS:	
		STREET 1:		200 CONNELL DRIVE
		STREET 2:		SUITE 1500
		CITY:			BERKELEY HEIGHTS
		STATE:			NJ
		ZIP:			07922

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCYTE THERAPIES INC
		DATE OF NAME CHANGE:	20001218
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>form312227001_01082025.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: form312227001_01082025.html

Document 1 - RAW XML: form312227001_01082025.xml

</DOCUMENT>
</SEC-DOCUMENT>